You are here
- Home
- Therapy Areas
- Cardiovascular
Cholesterol Goal Attainment rate and its associated factors among
dyslipidemic Patients on lipid-lowering drug therapy in Korea
(CRESCENDO study)
- Disease
- dyslipidaemia
- Drug Name
- non drug study (cardiovascular)
- Generic Name
- No Drug
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Aug 17, 2011
- Study Name
- CRESCENDO
- Study Id
- NIS-CKR-XXX-2011/1
- ClinicalTrials.gov ID
- NCT01372956
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 23, 2012
